Identification by [Tc-99]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease(508 views) Varrone A, Pagani M, Salvatore E, Salmaso D, Sansone V, Amboni M, Nobili F, De Michele G, Filla A, Barone P, Pappata S, Salvatore M
Biostructure and Bioimaging Institute, National Research Council/Department of Biomorphological and Functional Sciences, University Federico II, Napoli, Italy
Institute of Cognitive Sciences and Technologies, National Research Council, Rome, Italy
Department of Neurological Sciences, University Federico II, Napoli, Italy
Clinical Neurophysiology, Department of Endocrinological and Metabolic Sciences, University of Genoa, Genoa, Italy
Department of Clinical Neuroscience, Psychiatry Section, R5:02 Karolinska Hospital, Stockholm 17176, Sweden
References: Litvan, I., Campbell, G., Mangone, C.A., Verny, M., McKee, A., Chaudhuri, K.R., Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? a clinicopathological study (1997) Brain, 120, pp. 65-74. , Pt
Litvan, I., Agid, Y., Jankovic, J., Goetz, C., Brandel, J.P., Lai, E.C., Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) (1996) Neurology, 46, pp. 922-930
Williams, D.R., De Silva, R., Paviour, D.C., Pittman, A., Watt, H.C., Kilford, L., Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism (2005) Brain, 128, pp. 1247-1258
D'Antona, R., Baron, J.C., Samson, Y., Serdaru, M., Viader, F., Agid, Y., Subcortical dementia. Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy (1985) Brain, 108, pp. 785-799. , Pt 3
Foster, N.L., Gilman, S., Berent, S., Morin, E.M., Brown, M.B., Koeppe, R.A., Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography (1988) Ann Neurol, 24, pp. 399-406
Brooks, D.J., Ibanez, V., Sawle, G.V., Playford, E.D., Quinn, N., Mathias, C.J., Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography (1992) Ann Neurol, 31, pp. 184-192
Blin, J., Baron, J.C., Dubois, B., Pillon, B., Cambon, H., Cambier, J., Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations (1990) Arch Neurol, 47, pp. 747-752
Garraux, G., Salmon, E., Degueldre, C., Lemaire, C., Laureys, S., Franck, G., Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia (1999) Neuroimage, 10, pp. 149-162
Salmon, E., Van Der Linden, M.V., Franck, G., Anterior cingulate and motor network metabolic impairment in progressive supranuclear palsy (1997) Neuroimage, 5, pp. 173-178
Eckert, T., Barnes, A., Dhawan, V., Frucht, S., Gordon, M.F., Feigin, A.S., FDG PET in the differential diagnosis of parkinsonian disorders (2005) Neuroimage, 26, pp. 912-921
Klein, R.C., De Jong, B.M., De Vries, J.J., Leenders, K.L., Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease (2005) Mov Disord, 20, pp. 1021-1030
Burn, D.J., Rinne, J.O., Quinn, N.P., Lees, A.J., Marsden, C.D., Brooks, D.J., Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome, a [11C] diprenorphine PET study (1995) Brain, 118, pp. 951-958. , Pt 4
Shinotoh, H., Namba, H., Yamaguchi, M., Fukushi, K., Nagatsuka, S., Iyo, M., Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson's disease and progressive supranuclear palsy (1999) Ann Neurol, 46, pp. 62-69
Messa, C., Volonte, M.A., Fazio, F., Zito, F., Carpinelli, A., D'Amico, A., Differential distribution of striatal [123I]beta-CIT in Parkinson's disease and progressive supranuclear palsy, evaluated with single-photon emission tomography (1998) Eur J Nucl Med, 25, pp. 1270-1276
Ilgin, N., Zubieta, J., Reich, S.G., Dannals, R.F., Ravert, H.T., Frost, J.J., PET imaging of the dopamine transporter in progressive supranuclear palsy and Parkinson's disease (1999) Neurology, 52, pp. 1221-1226
Oyanagi, C., Katsumi, Y., Hanakawa, T., Hayashi, T., Thuy, D.D., Hashikawa, K., Comparison of striatal dopamine D2 receptors in Parkinson's disease and progressive supranuclear palsy patients using [123I] iodobenzofuran single-photon emission computed tomography (2002) J Neuroimaging, 12, pp. 316-324
Kim, Y.J., Ichise, M., Ballinger, J.R., Vines, D., Erami, S.S., Tatschida, T., Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP (2002) Mov Disord, 17, pp. 303-312
Defebvre, L., Lecouffe, P., Destee, A., Houdart, P., Steinling, M., Tomographic measurements of regional cerebral blood flow in progressive supranuclear palsy and Parkinson's disease (1995) Acta Neurol Scand, 92, pp. 235-341
Zhang, L., Murata, Y., Ishida, R., Saitoh, Y., Mizusawa, H., Shibuya, H., Differentiating between progressive supranuclear palsy and corticobasal degeneration by brain perfusion SPECT (2001) Nucl Med Commun, 22, pp. 767-772
Van Laere, K., Casteels, C., De Ceuninck, L., Vanbilloen, B., Maes, A., Mortelmans, L., Dual-tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis (2006) J Nucl Med, 47, pp. 384-392
Eidelberg, D., Moeller, J.R., Dhawan, V., Sidtis, J.J., Ginos, J.Z., Strother, S.C., The metabolic anatomy of Parkinson's disease: Complementary [ 18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies (1990) Mov Disord, 5, pp. 203-213
Lozza, C., Baron, J.C., Eidelberg, D., Mentis, M.J., Carbon, M., Marie, R.M., Executive processes in Parkinson's disease: FDG-PET and network analysis (2004) Hum Brain Mapp, 22, pp. 236-245
Gibb, W.R., Lees, A.J., The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease (1988) J Neurol Neurosurg Psychiatry, 51, pp. 745-752
Van Laere, K., Santens, P., Bosman, T., De Reuck, J., Mortelmans, L., Dierckx, R., Statistical parametric mapping of 99mTc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkinsonian features: Correlation with clinical parameters (2004) J Nucl Med, 45, pp. 933-942
Greitz, T., Bohm, C., Holte, S., Eriksson, L., A computerized brain atlas: Construction, anatomical content, and some applications (1991) J Comput Assist Tomogr, 15, pp. 26-38
Thurfjell, L., Bohm, C., Bengtsson, E., CBA-an atlas-based software tool used to facilitate the interpretation of neuroimaging data (1995) Comput Methods Programs Biomed, 47, pp. 51-71
Pett, M., Lackey, N., Sullivan, J., (2003) Making Sense of Factor Analysis: A Practical Guide to Understanding Factor Analysis for Instrument Development in Health Care Research, , Sage Publication, Inc. Thousand Oaks, CA
Hosaka, K., Ishii, K., Sakamoto, S., Mori, T., Sasaki, M., Hirono, N., Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration (2002) J Neurol Sci, 199, pp. 67-71
Badgaiyan, R.D., Executive control, willed actions, and nonconscious processing (2000) Hum Brain Mapp, 9, pp. 38-41
Pardo, J.V., Pardo, P.J., Janer, K.W., Raichle, M.E., The anterior cingulate cortex mediates processing selection in the Stroop attentional conflict paradigm (1990) Proc Natl Acad Sci USA, 87, pp. 256-259
Carter, C.S., Mintun, M., Cohen, J.D., Interference and facilitation effects during selective attention: An H215O PET study of Stroop task performance (1995) Neuroimage, 2, pp. 264-272
Devinsky, O., Morrell, M.J., Vogt, B.A., Contributions of anterior cingulate cortex to behaviour (1995) Brain, 118, pp. 279-306. , Pt 1
Morris, J., Dolan, R., Frackowiak, R.S.J., Friston, F.K., Frith, C.D., Dolan, R.J., Zeki, S., Price, C.J., Functional neuroanatomy of human emotion (2004) Human Brain Function, pp. 365-396. , 2 Elsevier Academic Press San Diego
Frith, C., Gallagher, H., Maguire, E., Mechanisms of control (2004) Human Brain Function. 2nd Ed., pp. 329-362. , Chapter 18. In: Frackowiak RSJ, Friston KJ, Frith CD, Dolan RJ, Zeki S, Price CJ, editors. San Diego: Elsevier
Migneco, O., Benoit, M., Koulibaly, P.M., Dygai, I., Bertogliati, C., Desvignes, P., Perfusion brain SPECT and statistical parametric mapping analysis indicate that apathy is a cingulate syndrome: A study in Alzheimer's disease and nondemented patients (2001) Neuroimage, 13, pp. 896-902
Foster, N.L., Minoshima, S., Johanns, J., Little, R., Heumann, M.L., Kuhl, D.E., PET measures of benzodiazepine receptors in progressive supranuclear palsy (2000) Neurology, 54, pp. 1768-1773
Abe, Y., Kachi, T., Kato, T., Arahata, Y., Yamada, T., Washimi, Y., Occipital hypoperfusion in Parkinson's disease without dementia: Correlation to impaired cortical visual processing (2003) J Neurol Neurosurg Psychiatry, 74, pp. 419-422
Juh, R., Kim, J., Moon, D., Choe, B., Suh, T., Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET (2004) Eur J Radiol, 51, pp. 223-233
Alexander, G.E., Delong, M.R., Strick, P.L., Parallel organization of functionally segregated circuits linking basal ganglia and cortex (1986) Annu Rev Neurosci, 9, pp. 357-381
Middleton, F.A., Strick, P.L., Basal ganglia output and cognition: Evidence from anatomical, behavioral, and clinical studies (2000) Brain Cogn, 42, pp. 183-200
Franceschi, M., Anchisi, D., Pelati, O., Zuffi, M., Matarrese, M., Moresco, R.M., Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration (2005) Ann Neurol, 57, pp. 216-225
Minoshima, S., Giordani, B., Berent, S., Frey, K.A., Foster, N.L., Kuhl, D.E., Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease (1997) Ann Neurol, 42, pp. 85-94
Lopez, O.L., Litvan, I., Catt, K.E., Stowe, R., Klunk, W., Kaufer, D.I., Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias (1999) Neurology, 53, pp. 1292-1299
Brenneis, C., Seppi, K., Schocke, M., Benke, T., Wenning, G.K., Poewe, W., Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy (2004) J Neurol Neurosurg Psychiatry, 75, pp. 246-249
Price, S., Paviour, D., Scahill, R., Stevens, J., Rossor, M., Lees, A., Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease (2004) Neuroimage, 23, pp. 663-669
Cordato, N.J., Duggins, A.J., Halliday, G.M., Morris, J.G., Pantelis, C., Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy (2005) Brain, 128, pp. 1259-1266
Identification by [Tc-99]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease
Purpose Progressive supranuclear palsy (PSP) is an akinetic-rigid syndrome that can be difficult to differentiate from Parkinson's disease (PD), particularly at an early stage. [Tc-99m] ethyl cysteinate dimer (ECD) SPECT could represent a widely available tool to assist in the differential diagnosis. In this study we used voxel-based analysis and Computerised Brain Atlas (CBA)-based principal component analysis (PCA) of [Tc-99m] ECD SPECT data to test whether: ( 1) specific patterns of rCBF abnormalities can differentiate PSP from controls and PD; ( 2) networks of dysfunctional brain regions can be found in PSP vs controls and PD. Methods Nine PD patients, 16 PSP patients and ten controls were studied with [Tc-99m] ECD SPECT using a brain-dedicated device (Ceraspect). Voxel-based analysis was performed with statistical parametric mapping. PCA was applied to volume of interest data after spatial normalisation to CBA. Results The voxel-based analysis showed hypoperfusion of the anterior cingulate and medial frontal cortex in PSP compared with controls and PD. In PSP patients the rCBF impairment extended to the pre-supplementary motor area and prefrontal cortex, areas involved in executive function and motor networks. Compared with PSP patients, PD patients showed a mild rCBF decrease in associative visual areas which could be related to the known impairment of visuospatial function. The PCA identified three principal components differentiating PSP patients from controls and/or PD patients that included groups of cortical and subcortical brain regions with relatively decreased ( cingulate cortex, prefrontal cortex and caudate) or increased ( parietal cortex) rCBF, representing distinct functional networks in PSP. Conclusion Anterior cingulate hypoperfusion seems to be an early, distinct brain abnormality in PSP as compared with PD.
Identification by [Tc-99]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease
No results.
Identification by [Tc-99]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease